142 related articles for article (PubMed ID: 21247442)
1. Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors.
Schmitz JC; Chu E
Silence; 2011 Jan; 2(1):1. PubMed ID: 21247442
[TBL] [Abstract][Full Text] [Related]
2. Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds.
Schmitz JC; Chen TM; Chu E
Cancer Res; 2004 Feb; 64(4):1431-5. PubMed ID: 14973067
[TBL] [Abstract][Full Text] [Related]
3. Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicity.
Wu SY; Chen TM; Gmeiner WH; Chu E; Schmitz JC
Nucleic Acids Res; 2013 Apr; 41(8):4650-9. PubMed ID: 23449220
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
5. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
6. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
7. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.
Miyagishi M; Taira K
Nat Biotechnol; 2002 May; 20(5):497-500. PubMed ID: 11981564
[TBL] [Abstract][Full Text] [Related]
8. Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma.
Höbel S; Appeldoorn CC; Gaillard PJ; Aigner A
Pharmaceuticals (Basel); 2011 Dec; 4(12):1591-1606. PubMed ID: 27721338
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing mediated by small interfering RNAs in mammalian cells.
Scherr M; Morgan MA; Eder M
Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
11. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
12. The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.
Raof NA; Rajamani D; Chu HC; Gurav A; Johnson JM; LoGerfo FW; Pradhan-Nabzdyk L; Bhasin M
BMC Genomics; 2016 Jan; 17():20. PubMed ID: 26728506
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
14. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
Naito Y; Yoshimura J; Morishita S; Ui-Tei K
BMC Bioinformatics; 2009 Nov; 10():392. PubMed ID: 19948054
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
16. Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing.
Posocco P; Liu X; Laurini E; Marson D; Chen C; Liu C; Fermeglia M; Rocchi P; Pricl S; Peng L
Mol Pharm; 2013 Aug; 10(8):3262-73. PubMed ID: 23841848
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism.
Armstrong ME; Gantier M; Li L; Chung WY; McCann A; Baugh JA; Donnelly SC
J Immunol; 2008 Jun; 180(11):7125-33. PubMed ID: 18490711
[TBL] [Abstract][Full Text] [Related]
18. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.
Elbashir SM; Martinez J; Patkaniowska A; Lendeckel W; Tuschl T
EMBO J; 2001 Dec; 20(23):6877-88. PubMed ID: 11726523
[TBL] [Abstract][Full Text] [Related]
19. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor gene expression by T7-siRNAs in cultured human retinal pigment epithelial cells.
Li GY; Fan B; Wu YZ; Wang XR; Wang YH; Wu JX
Chin Med J (Engl); 2005 Apr; 118(7):567-73. PubMed ID: 15820087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
